LIAISON Multi-Control Tumour Markers - Taiwan Registration 363068c39d695d065dc40e757b0099db
Access comprehensive regulatory information for LIAISON Multi-Control Tumour Markers in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 363068c39d695d065dc40e757b0099db and manufactured by DIASORIN ITALIA S.P.A.. The authorized representative in Taiwan is MEDRICH INSTRUMENT CO., LTD..
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Device Details
Registration Details
363068c39d695d065dc40e757b0099db
Ministry of Health Medical Device Import No. 030512
DHA05603051201
Product Details
This product is designed to provide reliability in the analysis of tumor markers (AFP, CA 125 II, CA 15-3, CA 19-9, CEA, Ferritin, HCG and ฮฒ2-Microglobulin) in serum by LIAISON and LIAISON XL automated immunofluorescence analyzers.
A Clinical chemistry and clinical toxicology
A1660 Quality Control Materials (Analytical and Non-Analytical)
Imported from abroad
Dates and Status
Feb 27, 2018
Feb 27, 2028

